CIK 0001668397
- Large accelerated filer
Medpace Holdings, Inc.
Sign in to watch- Ticker
- MEDP
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320434904
- Phone
- +1 513-579-9911
- Business address
- 5375 MEDPACE WAY, CINCINNATI, OH, 45227
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $174,850,299
- in 14 filings
Net −$174,850,299. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-05 | BURWIG SUSAN E Exec. VP, Operations | Sale | −7,681 | $401.20 | $3.1M | 7,500 |
| 2024-05-28 | Troendle August J. CEO | Sale | −5,695 | $395.49 | $2.3M | 654,656 |
| 2024-05-24 | Troendle August J. CEO | Sale | −3,987 | $395.22 | $1.6M | 660,351 |
| 2024-05-22 | Troendle August J. CEO | Sale | −55 | $400.00 | $22K | 664,338 |
| 2024-05-20 | Troendle August J. CEO | Sale | −4,020 | $400.19 | $1.6M | 664,393 |
| 2024-05-17 | McCarthy Cornelius P. III Director | Grant or award · Stock Option (Right to Buy) | +953 | 953 | ||
| 2024-05-17 | Keating Ashley M. Director | Grant or award · Stock Option (Right to Buy) | +953 | 953 | ||
| 2024-05-17 | Gwadry-Sridhar Femida H. Director | Grant or award · Stock Option (Right to Buy) | +953 | 953 | ||
| 2024-05-17 | Kraft Robert O. Director | Grant or award · Stock Option (Right to Buy) | +953 | 953 | ||
| 2024-05-17 | Carley Brian T Director | Grant or award · Stock Option (Right to Buy) | +953 | 953 | ||
| 2024-05-17 | DAVENPORT FRED B JR Director | Grant or award · Stock Option (Right to Buy) | +953 | 953 | ||
| 2024-05-16 | Troendle August J. CEO | Sale | −7,060 | $403.09 | $2.8M | 668,413 |
| 2024-05-15 | Troendle August J. CEO | Sale | −32,282 | $405.13 | $13.1M | 675,473 |
| 2024-05-10 | Troendle August J. CEO | Sale | −4,956 | $402.89 | $2.0M | 707,755 |
| 2024-05-09 | Troendle August J. CEO | Sale | −3,486 | $400.17 | $1.4M | 712,711 |
| 2024-05-08 | Troendle August J. CEO | Sale | −4,782 | $400.58 | $1.9M | 716,197 |
| 2024-05-07 | Troendle August J. CEO | Sale | −28,032 | $404.48 | $11.3M | 720,979 |
| 2024-05-06 | Troendle August J. CEO | Sale | −24,372 | $401.73 | $9.8M | 749,011 |
| 2024-05-02 | Troendle August J. CEO | Sale | −3,396 | $400.44 | $1.4M | 773,383 |
| 2024-05-01 | Troendle August J. CEO | Sale | −12,934 | $401.56 | $5.2M | 776,779 |
Page 14 of 20 · 391 trades